{"id":242,"date":"2014-01-17T18:50:00","date_gmt":"2014-01-17T23:50:00","guid":{"rendered":"https:\/\/med.sites.unc.edu\/urology\/patientinfo\/cancer\/"},"modified":"2025-08-26T13:36:48","modified_gmt":"2025-08-26T17:36:48","slug":"cancer","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/urology\/patientcare\/cancer\/","title":{"rendered":"Cancer"},"content":{"rendered":"

Our Urologic Oncology faculty have partnered with oncology specialists from the departments of Surgery, Medicine, Radiation Therapy, Radiology, Pathology, and Nursing to form a dedicated patient care team that delivers individualized care in a coordinated and caring manner. We know that a cancer diagnosis can be difficult and we are committed to helping you navigate this journey.<\/p>\n

\n
\n
\n

Bladder Cancer<\/a><\/h2>\n

There are several subtypes of bladder cancer and each behaves differently, but the most common subtype of bladder cancer is \u201curothelial\u201d cancer. An older term is \u201ctransitional cell\u201d cancer.<\/p>\n<\/div>\n

\n

Kidney Cancer<\/a><\/h2>\n

More than 60,000 people are diagnosed with kidney cancer in the United States each year, both men and women, although men are diagnosed more often.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Prostate Cancer<\/a><\/h2>\n

Prostate cancer is the most common non-skin cancer of men in the United States with over 200,000 new cases diagnosed each year. Prostate cancer can only develop in males, as the prostate gland is not present in women.<\/p>\n<\/div>\n

\n

Testicular Cancer<\/a><\/h2>\n

The incidence of testicular cancer in the United States is 5\/100,000 men resulting in approximately 8,400 cases per year.<\/p>\n<\/div>\n<\/div>\n

 
\nLeadership<\/h2>\n

\n \n
\n
\n \t\t\n
\n \"Dr.\n \"\"\n <\/div>\t\t\t\t\t\t\t\t\t\n <\/div>\n
\n

\n Hung-Jui (Ray) Tan, MD, MSHPM <\/a>\n <\/h2> \n \n

Chief of the Division of Urologic Oncology
\nUrologic Oncology Fellowship Program Director
\nAssociate Professor of Urology<\/p>\n <\/div>\n <\/article>\n\n \n